- Big pharma moves to early stage deals
- Paul Hastings on big biotechs as dealmakers
- Pluristem: Adaptive cells create new approach
partnering360®: leverage and cultivate your dealmaker network
partnering360 is the network for dealmakers in the life science industry. This global community of more than 23,000 is constantly growing, and the partnering opportunities continually updating.